PHARMA BASE: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
PHARMA BASE
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2023 against 2024filed annual accounts (NBB)
Net result for the year
€178,876
2023 · €41,833+€137,042
Equity
€2.5m
2023 · €2.3m+€178,876
Cash
€645,070
2023 · €1.7m-€1.1m
Balance sheet total
€21.1m
2023 · €19.1m+€2.0m
Largest movements
Assets
- Stocks and contracts +€2.0m
up €2.0m (+42.6%), from €4.7m to €6.6m
- Cash -€1.1m
down €1.1m (-62.6%), from €1.7m to €645,070
mainly Stocks and contracts (-€2.0m) and Receivables within one year (-€1.1m)
- Receivables within one year +€1.1m
up €1.1m (+8.8%), from €12.1m to €13.2m
of which Other amounts receivable: +€3.5m
Equity and liabilities
- Trade debts +€887,755
up €887,755 (+8.4%), from €10.5m to €11.4m
- Short-term financial debts +€588,274
up €588,274 (+29.2%), from €2.0m to €2.6m
of which Credit institutions: +€540,274
- Other debts +€362,591
up €362,591 (+9.4%), from €3.9m to €4.2m
Income statement
- Turnover +€15.1m
up €15.1m (+25.1%), from €60.2m to €75.2m
- Goods and materials +€14.4m
up €14.4m (+25.6%), from €56.3m to €70.6m
of which Purchases: +€15.8m
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2023
€41,833
Turnover
+€15.1m
Other operating income
+€144,448
Goods and materials
-€14.4m
Services and other goods
-€405,284
Staff costs
-€255,110
Depreciation
-€7,098
Other operating charges
+€4,700
Other operating items
-€52,035
Financial income
+€820
Financial charges
-€37,439
Taxes
+€49,967
Result 2024
€178,876
Cash bridge derived
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€1.5m
Investment
-€109,391
Financing
+€555,423
Cash 2023
€1.7m
From operations (derived)
-€1.5m
Net result for the year
+€178,876
Depreciation
+€115,308
Stocks and contracts
-€2.0m
Receivables within one year
-€1.1m
Deferred charges and accrued income
-€17,746
Trade debts
+€887,755
Smaller working-capital items
-€5,159
Other debts
+€362,591
Investment (derived)
-€109,391
Investment in fixed assets (net)
-€109,391
Financing
+€555,423
Debts after one year
-€17,062
Current portion of long-term debt
-€15,789
Short-term financial debts
+€588,274
Cash 2024
€645,070
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €19,084,126 | €21,063,611 | +€2.0m | +10.4% |
| Fixed assets | 21/28 | €576,586 | €570,670 | -€5,917 | -1.0% |
| Intangible fixed assets | 21 | €415,887 | €381,182 | -€34,705 | -8.3% |
| Tangible fixed assets | 22/27 | €151,700 | €180,488 | +€28,788 | +19.0% |
| Plant, machinery and equipment | 23 | €19,821 | €24,873 | +€5,052 | +25.5% |
| Furniture and vehicles | 24 | €64,545 | €89,524 | +€24,979 | +38.7% |
| Leasing and similar rights | 25 | €30,841 | €39,903 | +€9,062 | +29.4% |
| Other tangible fixed assets | 26 | €36,492 | €26,188 | -€10,305 | -28.2% |
| Financial fixed assets | 28 | €9,000 | €9,000 | = | 0.0% |
| Other financial fixed assets | 284/8 | €9,000 | €9,000 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €9,000 | €9,000 | = | 0.0% |
| Current assets | 29/58 | €18,507,540 | €20,492,942 | +€2.0m | +10.7% |
| Stocks and contracts in progress | 3 | €4,654,870 | €6,639,523 | +€2.0m | +42.6% |
| Stocks | 30/36 | €4,654,870 | €6,639,523 | +€2.0m | +42.6% |
| Goods purchased for resale | 34 | €4,654,870 | €6,639,523 | +€2.0m | +42.6% |
| Amounts receivable within one year | 40/41 | €12,126,906 | €13,189,840 | +€1.1m | +8.8% |
| Trade receivables | 40 | €7,112,752 | €4,701,272 | -€2.4m | -33.9% |
| Other amounts receivable | 41 | €5,014,155 | €8,488,568 | +€3.5m | +69.3% |
| Cash at bank and in hand | 54/58 | €1,725,001 | €645,070 | -€1.1m | -62.6% |
| Deferred charges and accrued income | 490/1 | €762 | €18,508 | +€17,746 | +2328.2% |
| Total equity and liabilities | 10/49 | €19,084,126 | €21,063,611 | +€2.0m | +10.4% |
| Equity | 10/15 | €2,348,180 | €2,527,055 | +€178,876 | +7.6% |
| Contributions | 10/11 | €1,000,000 | €1,000,000 | = | 0.0% |
| Capital | 10 | €1,000,000 | €1,000,000 | = | 0.0% |
| Issued capital | 100 | €1,000,000 | €1,000,000 | = | 0.0% |
| Reserves | 13 | €1,348,180 | €1,527,055 | +€178,876 | +13.3% |
| Non-distributable reserves | 130/1 | €100,000 | €100,000 | = | 0.0% |
| Legal reserve | 130 | €100,000 | €100,000 | = | 0.0% |
| Distributable reserves | 133 | €1,248,180 | €1,427,055 | +€178,876 | +14.3% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €16,735,947 | €18,536,556 | +€1.8m | +10.8% |
| Amounts payable after more than one year | 17 | €49,960 | €32,898 | -€17,062 | -34.2% |
| Financial debts | 170/4 | €49,960 | €32,898 | -€17,062 | -34.2% |
| Leasing and similar obligations | 172 | €19,308 | €19,814 | +€506 | +2.6% |
| Credit institutions | 173 | €30,652 | €13,084 | -€17,568 | -57.3% |
| Amounts payable within one year | 42/48 | €16,683,591 | €18,503,417 | +€1.8m | +10.9% |
| Current portion of amounts payable after more than one year | 42 | €57,885 | €42,096 | -€15,789 | -27.3% |
| Financial debts | 43 | €2,011,778 | €2,600,052 | +€588,274 | +29.2% |
| Credit institutions | 430/8 | €2,011,778 | €2,552,052 | +€540,274 | +26.9% |
| Other loans | 439 | - | €48,000 | +€48,000 | |
| Trade debts | 44 | €10,544,857 | €11,432,611 | +€887,755 | +8.4% |
| Suppliers | 440/4 | €10,544,857 | €11,432,611 | +€887,755 | +8.4% |
| Taxes, remuneration and social security | 45 | €197,583 | €194,578 | -€3,005 | -1.5% |
| Taxes | 450/3 | €48,654 | €29,692 | -€18,961 | -39.0% |
| Remuneration and social security | 454/9 | €148,929 | €164,886 | +€15,956 | +10.7% |
| Other amounts payable | 47/48 | €3,871,489 | €4,234,080 | +€362,591 | +9.4% |
| Accrued charges and deferred income | 492/3 | €2,395 | €241 | -€2,154 | -89.9% |
| Operating income | 70/76A | €60,194,437 | €75,443,792 | +€15.2m | +25.3% |
| Turnover | 70 | €60,168,191 | €75,243,950 | +€15.1m | +25.1% |
| Other operating income | 74 | €25,034 | €169,482 | +€144,448 | +577.0% |
| Non-recurring operating income | 76A | €1,212 | €30,360 | +€29,148 | +2404.6% |
| Operating charges | 60/66A | €59,953,337 | €75,078,998 | +€15.1m | +25.2% |
| Goods for resale, raw materials and consumables | 60 | €56,263,137 | €70,644,823 | +€14.4m | +25.6% |
| Purchases | 600/8 | €56,818,643 | €72,629,475 | +€15.8m | +27.8% |
| Change in stocks: decrease (increase) | 609 | -€555,506 | -€1,984,652 | -€1.4m | -257.3% |
| Services and other goods | 61 | €2,492,801 | €2,898,085 | +€405,284 | +16.3% |
| Remuneration, social security and pensions | 62 | €1,059,189 | €1,314,299 | +€255,110 | +24.1% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €108,210 | €115,308 | +€7,098 | +6.6% |
| Other operating charges | 640/8 | €23,475 | €18,775 | -€4,700 | -20.0% |
| Non-recurring operating charges | 66A | €6,525 | €87,708 | +€81,183 | +1244.1% |
| Operating profit (loss) | 9901 | €241,100 | €364,794 | +€123,694 | +51.3% |
| Financial income | 75/76B | €5,424 | €6,244 | +€820 | +15.1% |
| Recurring financial income | 75 | €5,424 | €6,244 | +€820 | +15.1% |
| Other financial income | 752/9 | €5,424 | €6,244 | +€820 | +15.1% |
| Financial charges | 65/66B | €88,687 | €126,125 | +€37,439 | +42.2% |
| Recurring financial charges | 65 | €88,687 | €126,125 | +€37,439 | +42.2% |
| Debt charges | 650 | €84,486 | €121,428 | +€36,942 | +43.7% |
| Other financial charges | 652/9 | €4,201 | €4,698 | +€497 | +11.8% |
| Profit (loss) for the period before taxes | 9903 | €157,837 | €244,913 | +€87,075 | +55.2% |
| Income taxes | 67/77 | €116,004 | €66,037 | -€49,967 | -43.1% |
| Taxes | 670/3 | €116,004 | €66,037 | -€49,967 | -43.1% |
| Profit (loss) for the period | 9904 | €41,833 | €178,876 | +€137,042 | +327.6% |
| Profit (loss) for the period to be appropriated | 9905 | €41,833 | €178,876 | +€137,042 | +327.6% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 4 October 2026 via checked.be.